SCHEMBL21496438

SCHEMBL21496438

CC(C(=O)Nc1cnc(Cl)nc1)C12CC(NC(=O)c3ccc(Cl)c(Cl)c3)(C1)C2

nearest known ligand 0.66

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 13/20 0.66
▸ KCNQ3 O43525 5/20 0.46
▸ KCNQ2 O43526 5/20 0.46
▸ KCNE1 P15382 4/20 0.46
▸ KCNQ1 P51787 4/20 0.46
▸ KCNQ5 Q9NR82 4/20 0.46
▸ MAPT P10636 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ GAA P10253 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30055400 1.00 IDO1 (0.66) IDO1KCNQ3KCNQ2KCNE1KCNQ1
SCHEMBL21496437 1.00 IDO1 (0.66) IDO1KCNQ3KCNQ2KCNE1KCNQ1
SCHEMBL21496524 0.90 IDO1 (0.63) IDO1KCNQ3KCNQ2KCNE1KCNQ1
SCHEMBL30055204 0.90 IDO1 (0.77) IDO1KCNQ3KCNQ2KCNE1KCNQ1
SCHEMBL30055202 0.90 IDO1 (0.63) IDO1KCNQ3KCNQ2KCNE1KCNQ1
SCHEMBL24117916 0.90 IDO1 (0.77) IDO1KCNQ3KCNQ2KCNE1KCNQ1
SCHEMBL21496522 0.90 IDO1 (0.63) IDO1KCNQ3KCNQ2KCNE1KCNQ1
SCHEMBL29639835 0.88 IDO1 (0.69) IDO1KCNQ3KCNQ2KCNE1KCNQ1
SCHEMBL23572577 0.88 IDO1 (0.69) IDO1KCNQ3KCNQ2KCNE1KCNQ1
SCHEMBL21496536 0.87 IDO1 (0.68) IDO1KCNQ3KCNQ2KCNE1KCNQ1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3781142-A1 NOVEL [1.1.1] BICYCLO COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS Merck Sharp&Dohme Corp. (US) 2021-02-24 — — EP claimed
WO-2019204180-A1 NOVEL [1.1.1] BICYCLO COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2019-10-24 — — WO claimed
Send feedback